Full-Time

DEXIS Electrical Engineer

Multiple Teams

Posted on 8/12/2025

Envista

Envista

1,001-5,000 employees

Global dental products & technologies provider

Compensation Overview

$95k - $100k/yr

+ Annual Performance Bonus + 401K Match + Other Compensation Plans

Quakertown, PA, USA

Hybrid

Hybrid role requiring some in-office presence.

Category
Electrical Engineering (2)
,
Requirements
  • B.S. degree or equivalent in Electrical/Electronic Engineering Technology, Computer Engineering Technology, or Biomedical Engineering
  • 3+ years’ experience in the design / testing and analysis in electronic circuits
  • Basic understanding of device safety standard, IEC 60601-1 preferred
  • Working knowledge of analog / digital circuits
  • Experience with developing design documentation including formal test reports; participating in FMEA and design reviews
  • Excellent communication skills (written and verbal)
  • Ability to work independently and with a cross functional team
  • Occasional Travel: Up to 10%, as needed.
Responsibilities
  • Ensures timely completion of electrical engineering deliverables, such component selection, schematic capture, PCB layout, testing, etc.
  • Ensures all devices (new product and existing product changes) meet compliance, performance, and cost specifications.
  • Generates applicable QMS (quality management system) documentation such as theory of operation, formal design reviews, formal test reports as well as contributing content to user manuals.
  • Provides input to project scheduling and management.
  • Participates in and provides guidance for design reviews, FMEA, Risk Analysis and Usability Engineering activities.
  • Contributes to QMS procedure maintenance as applicable.
  • Obtains product certification/recognition to applicable EN, ISO & IEC 60601-1 general, collateral, and standards through 3rd party compliance laboratories (UL, ETL, TUV, BSI, etc.).
Desired Qualifications
  • M.S. degree preferred.
  • Medical device design and compliance experience.
  • Compliance Engineering: Performed GAP assessment, i.e. analyze product design and documentation vs. applicable standards and/or updates to standards.
  • Lead projects with 3rd party compliance laboratories (UL, ETL, TUV, BSI, etc.).
  • Has developed EMC test plans
  • Analog/Digital/Power Conversion circuit design.
  • Schematic Capture and the design of PCBs using CAD software (experience with Altium highly desirable).
  • Has analyzed schematics; test & trouble shoot PCB to component level; works with oscilloscopes, logic analyzers, spectrum analyzers, DMMs.
  • Has simulation tool experience.
  • Has firmware and software design experience with the ability to program in C and Python.
  • Has developed EMC Test Plans, conducted EMC evaluations, and EMC noncompliance mitigations.
  • Has developed system interconnect solutions i.e., cabling/wiring.
  • Contributed to cross-functional problem solving.
  • Collaboration with cross functional teams: mechanical engineering, software engineering, quality engineering, regulatory affairs.
  • Has developed FMEA, Risk Analysis and Usability Engineering documentation (ISO 14971 highly desirable).
  • Experience with FDA 510K cleared medical devices and has contributed to 510K submissions.
  • Experience with ISO quality management systems and processes (ISO 13485 highly desirable).
  • Designed and lead construction of test fixtures.
  • Fundamental understanding of: Design for Manufacturing, Sourcing, Assembly, Reliability Principles, Human Factors and Usability Engineering Considerations, Risk Analysis and Mitigation, Component selection, Value Engineering principles.

Envista provides a comprehensive range of dental products, including implants, orthodontic braces, clear aligners, and digital imaging equipment. These products work together to support nearly 90% of a dentist's clinical needs, from initial digital diagnosis and treatment planning to the physical tools used for surgery and infection prevention. Unlike many competitors that focus on a single niche, Envista offers a massive portfolio of established brands like Nobel Biocare and Ormco that cover both specialized surgery and everyday consumables. The company's goal is to provide dental professionals with a complete, integrated ecosystem of tools and software to improve patient outcomes globally.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Brea, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Aging populations and cosmetic dentistry trends drive implant and orthodontic demand.
  • Digital dentistry integration boosts case acceptance and practice operational efficiency.
  • Hitachi Digital partnership accelerates cloud transformation and operational scalability.

What critics are saying

  • Dentsply Sirona's superior CAD/CAM systems erode Nobel Biocare implant market share.
  • Align Technology's iTero and Invisalign lock dentists into proprietary workflows.
  • Chinese aligner producers undercut Spark Clear Aligners with 40% cheaper alternatives.

What makes Envista unique

  • Portfolio covers ~90% of dentist clinical needs across implants, orthodontics, imaging.
  • 30+ trusted brands including Nobel Biocare, Ormco, Kerr integrated post-Danaher spinoff.
  • AI and cloud-based software integrating imaging, aligners, practice management workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Performance Bonus

Company News

V3 Healthcare
Nov 27th, 2025
Envista Announces Participation in 8th Annual Evercore Healthcare Conference

Envista announces participation in 8th Annual Evercore Healthcare Conference. BREA, Calif., Nov. 25, 2025 /PRNewswire/ - Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference. The fireside chat will take place on Wednesday, December 3, 2025, from 12:30 - 1:15 pm ET. A live audio webcast of the event, along with an archived replay, will be available in the Investors section of the Envista website athttps://investors.envistaco.com/. Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com. FOR FURTHER INFORMATION Jim Gustafson Vice President, Investor Relations Envista Holdings Corporation 200 S. Kraemer Blvd., Building E Brea, CA 92821 [emailprotected] SOURCE Envista Holdings Corporation

Technology AI Insights
May 16th, 2025
Hitachi Digital, Envista Form Five-Year Strategic IT Partnership

Following a highly competitive tendering process, Envista selected Hitachi Digital Services as its strategic IT partner to support its digital transformation and operational efficiency goals.

PR Newswire
May 1st, 2025
Envista Reports First Quarter 2025 Results

BREA, Calif., May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended March 28, 2025. "In the first quarter, Envista delivered results in line with our expectations building on the momentum established across the second half of 2024," said Paul Keel, CEO. "We continued to drive improvements across our three priority areas of growth, operations, and people. This was a solid start to the year, and we are maintaining our 2025 guidance.". Q1 2025 financial highlights: Sales were $617 million, with core sales increasing 0.2% over the first quarter of 2024

PR Newswire
Feb 25th, 2025
Envista Smile Project Donates $1.8 Million In 2024

BREA, Calif., Feb. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") proudly announced that in 2024, the Envista Smile Project (Smile Project) contributed $1.8 million to further its mission of enhancing oral health accessibility for underserved communities.Since its inception in 2021, the Envista Smile Project has delivered over $4.2 million in dental goods and services, positively impacting approximately 32,000 individuals worldwide.In 2024, the Envista Smile Project:Supplied free dental care to more than 787 patients in the Dominican Republic. Donated goods for cleaning, cavity prevention and treatment, and consumables to free dental clinics managed by Heartland Dental and the Illumination Foundation totaling more than 5,600 patients.Provided portable x-ray access to the Colorado Mission of Mercy, Rhode Island Mission of Mercy, New Mexico Mission of Mercy, Nurturing Smiles, Seattle /King County Clinic, Michigan Dental Association, and Special Olympics New Jersey./King County Clinic, Michigan Dental Association, and Special Olympics New Jersey. Partnered with the University of Southern California's ( USC ) Herman Ostrow School of Dentistry to support USC's Dental Health Equity and Access to Care Initiative.( ) of Dentistry to support Dental Health Equity and Access to Care Initiative. Sponsored five senior residents to Jamaica with Great Shape/1000 Smiles, where they treated over 1661 patients with no access to oral care."At Envista, we believe that oral health is a fundamental part of overall well-being, and we are proud to support communities in need through the Smile Project," said Rubin Casas, Envista Smile Project Board President. "By working alongside dedicated dental professionals and volunteers, we continue to make a meaningful impact—restoring smiles, improving health, and changing lives."Envista Smile Project is a philanthropic foundation designed to improve the oral health of disadvantaged communities by supporting increased access to oral care and oral health education

PR Newswire
Feb 4th, 2025
Envista To Hold Capital Markets Day On March 5, 2025

BREA, Calif., Feb. 4, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will hold a Capital Markets Day on Wednesday, March 5, from 9:00 a.m. to 12:00 p.m. EST. This event will include a management presentation followed by a question-and-answer session. In-person attendance requires advanced registration

INACTIVE